Statera Biopharma, Inc. Selling, General and Administrative Expense
Statera Biopharma, Inc. reported Selling, General and Administrative Expense of $3.48 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2013-05-09
- Statera Biopharma, Inc. selling, general and administrative expense for the quarter ending 2013-03-31 was $3.48M, a 43.50% increase year-over-year.
- Statera Biopharma, Inc. selling, general and administrative expense for the quarter ending 2012-12-31 was $2.14M, a 28.67% decline year-over-year.
- Statera Biopharma, Inc. selling, general and administrative expense for the quarter ending 2012-09-30 was $3.22M, a 24.06% decline year-over-year.
- Statera Biopharma, Inc. selling, general and administrative expense for the quarter ending 2012-06-30 was $3.33M, a 67.38% increase year-over-year.
- Statera Biopharma, Inc. selling, general and administrative expense for fiscal 2012 was $11.12M, a 0.08% increase from fiscal 2011.
- Statera Biopharma, Inc. selling, general and administrative expense for fiscal 2011 was $11.11M, a 11.87% increase from fiscal 2010.
- Statera Biopharma, Inc. selling, general and administrative expense for fiscal 2010 was $9.93M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2013-03-31 | $3.48M 10-Q · filed 2013-05-09 | $5.62M derived: sum of 2 quarters · filed 2013-05-09 | $8.84M derived: sum of 3 quarters · filed 2013-05-09 | $12.17M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.36M derived: sum of 2 quarters · filed 2013-03-18 | $8.69M derived: sum of 3 quarters · filed 2013-03-18 | $11.12M 10-K · filed 2013-03-18 |
| 2012-09-30 | $3.22M 10-Q · filed 2012-11-09 | $6.55M derived: sum of 2 quarters · filed 2012-11-09 | $8.97M 10-Q · filed 2012-11-09 | $11.98M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-06-30 | $3.33M 10-Q · filed 2012-08-09 | $5.75M 10-Q · filed 2012-08-09 | $8.76M derived: sum of 3 quarters · filed 2013-05-09 | $13.00M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-03-31 | $2.43M 10-Q · filed 2013-05-09 | $5.43M derived: sum of 2 quarters · filed 2013-05-09 | $9.67M derived: sum of 3 quarters · filed 2013-05-09 | $11.66M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $7.24M derived: sum of 2 quarters · filed 2013-03-18 | $9.23M derived: sum of 3 quarters · filed 2013-03-18 | $11.11M 10-K · filed 2013-03-18 |
| 2011-09-30 | $4.24M 10-Q · filed 2012-11-09 | $6.23M derived: sum of 2 quarters · filed 2012-11-09 | $8.10M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $1.99M 10-Q · filed 2012-08-09 | $3.86M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $4.26M derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $5.34M derived: sum of 2 quarters · filed 2013-03-18 | $8.00M derived: sum of 3 quarters · filed 2013-03-18 | $9.93M 10-K · filed 2013-03-18 |
| 2010-09-30 | $1.07M 10-Q/A · filed 2011-11-14 | $3.73M derived: sum of 2 quarters · filed 2011-11-14 | $5.66M 10-Q/A · filed 2011-11-14 | |
| 2010-06-30 | $2.66M 10-Q · filed 2011-08-09 | $4.59M 10-Q · filed 2011-08-09 |